These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2516632

  • 1. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN, Das S, Bansinath M, Prasad R.
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [Abstract] [Full Text] [Related]

  • 2. Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats.
    Rahmani NH, Gulati A, Bhargava HN.
    Peptides; 1990 Sep; 11(4):693-5. PubMed ID: 2172939
    [Abstract] [Full Text] [Related]

  • 3. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats.
    Bhargava HN, Ramarao P, Gulati A, Matwyshyn GA, Prasad R.
    Arch Int Pharmacodyn Ther; 1989 Sep; 297():247-59. PubMed ID: 2499290
    [Abstract] [Full Text] [Related]

  • 4. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [Abstract] [Full Text] [Related]

  • 5. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN, Das S, Bansinath M.
    Peptides; 1987 Mar; 8(2):231-5. PubMed ID: 3035513
    [Abstract] [Full Text] [Related]

  • 6. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN, Gulati A.
    Peptides; 1988 Mar; 9(4):771-5. PubMed ID: 2852360
    [Abstract] [Full Text] [Related]

  • 7. Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.
    Gudehithlu KP, Reddy PL, Bhargava HN.
    Brain Res; 1994 Mar 14; 639(2):269-74. PubMed ID: 7911390
    [Abstract] [Full Text] [Related]

  • 8. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats.
    Gudehithlu KP, Tejwani GA, Bhargava HN.
    Brain Res; 1991 Jul 12; 553(2):284-90. PubMed ID: 1933285
    [Abstract] [Full Text] [Related]

  • 9. Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats.
    Gulati A, Bhargava HN.
    Eur J Pharmacol; 1989 Aug 22; 167(2):185-92. PubMed ID: 2591474
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Aug 22; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 11. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN, Gulati A.
    J Pharmacol Exp Ther; 1990 Mar 22; 252(3):901-7. PubMed ID: 2138669
    [Abstract] [Full Text] [Related]

  • 12. Brain and pituitary receptors for thyrotropin-releasing hormone in hypothyroid rats.
    Bhargava HN, Ramarao P, Gulati A, Matwyshyn GA, Prasad R.
    Pharmacology; 1989 Mar 22; 38(4):243-52. PubMed ID: 2755964
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN, Gulati A, Rahmani NH.
    Neuropharmacology; 1992 Feb 22; 31(2):137-41. PubMed ID: 1313157
    [Abstract] [Full Text] [Related]

  • 14. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN, Das S, Gulati A.
    J Pharm Pharmacol; 1988 Jan 22; 40(1):70-2. PubMed ID: 2896784
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug 22; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 16. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats.
    Reddy PL, Veeranna, Thorat SN, Bhargava HN.
    Brain Res; 1993 Apr 02; 607(1-2):293-300. PubMed ID: 8481804
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.
    Gulati A, Bhargava HN.
    Eur J Pharmacol; 1990 Jul 03; 182(2):253-9. PubMed ID: 2144490
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN, Gulati A.
    Eur J Pharmacol; 1990 Nov 13; 190(3):305-11. PubMed ID: 2176984
    [Abstract] [Full Text] [Related]

  • 20. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ, Lautens LL, Tashjian AH.
    Mol Endocrinol; 1987 Dec 13; 1(12):889-98. PubMed ID: 2856405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.